ANI Pharmaceuticals, Inc. (ANIP)
81.85
+0.65
(+0.80%)
USD |
NASDAQ |
Jun 10, 16:00
81.76
-0.09
(-0.11%)
After-Hours: 20:00
ANI Pharmaceuticals 1 Year Total Returns (Daily) : 30.19% for June 10, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| June 10, 2026 | 30.19% |
| June 09, 2026 | 28.52% |
| June 08, 2026 | 29.33% |
| June 05, 2026 | 35.45% |
| June 04, 2026 | 30.11% |
| June 03, 2026 | 22.01% |
| June 02, 2026 | 20.58% |
| June 01, 2026 | 30.64% |
| May 29, 2026 | 34.76% |
| May 28, 2026 | 40.30% |
| May 27, 2026 | 40.19% |
| May 26, 2026 | 40.87% |
| May 22, 2026 | 44.44% |
| May 21, 2026 | 40.10% |
| May 20, 2026 | 35.22% |
| May 19, 2026 | 33.51% |
| May 18, 2026 | 32.26% |
| May 15, 2026 | 31.04% |
| May 14, 2026 | 31.82% |
| May 13, 2026 | 30.45% |
| May 12, 2026 | 27.61% |
| May 11, 2026 | 18.72% |
| May 08, 2026 | 14.44% |
| May 07, 2026 | 18.48% |
| May 06, 2026 | 19.62% |
| Date | Value |
|---|---|
| May 05, 2026 | 16.63% |
| May 04, 2026 | 12.84% |
| May 01, 2026 | 13.72% |
| April 30, 2026 | 12.19% |
| April 29, 2026 | 10.19% |
| April 28, 2026 | 10.95% |
| April 27, 2026 | 14.01% |
| April 24, 2026 | 12.92% |
| April 23, 2026 | 14.17% |
| April 22, 2026 | 16.23% |
| April 21, 2026 | 17.56% |
| April 20, 2026 | 18.09% |
| April 17, 2026 | 16.92% |
| April 16, 2026 | 12.82% |
| April 15, 2026 | 9.96% |
| April 14, 2026 | 13.93% |
| April 13, 2026 | 14.96% |
| April 10, 2026 | 20.33% |
| April 09, 2026 | 21.41% |
| April 08, 2026 | 25.31% |
| April 07, 2026 | 18.63% |
| April 06, 2026 | 14.34% |
| April 02, 2026 | 6.99% |
| April 01, 2026 | 11.67% |
| March 31, 2026 | 14.86% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Indivior Pharmaceuticals, Inc. | 178.2% |
| Liquidia Corp. | 335.6% |
| Phathom Pharmaceuticals, Inc. | 9.48% |
| Catalyst Pharmaceuticals, Inc. | 19.12% |
| AbbVie, Inc. | 22.60% |